ALS News | ALS Therapy Development Institute

ALS Research News

Friday, January 17, 2020

Science Sunday - Limb and Bulbar Onset ALS

ALS disease onset typically occurs in one of two main ways: Limb Onset or Bulbar Onset.

Friday, January 10, 2020

Science Sunday - Our Team is Growing

Over the last year the science team at the ALS Therapy Development Institute has welcomed new members to help in the fight to find a cure for ALS.

Wednesday, December 18, 2019

Project Euphonia FAQ

ALS TDI is proud to share that we have been featured in episode two of “The Age of A.I.,” a new YouTube Originals documentary series that takes an immersive look at artificial intelligence and its potential to change the world.

From trial readouts to news from our lab, you can find all of the latest ALS research news here.

More ALS Research News

ALS TDI Community Blog

Friday, January 17, 2020

50in1 to End ALS

50in1 crawl to end ALS to take place on January 25, 2020.

Wednesday, January 08, 2020

The PeriodicALS: Volume 21 Issue 1

January 2020 news from the ALS Therapy Development Institute.

Thursday, January 02, 2020

Ales for ALS™ 2020

Since 2013, the Ales for ALS™ program has raised over $3 million for research at the ALS Therapy Development Institute.

Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Wednesday, December 18, 2019

ALS TDI Collaboration with Google’s Project Euphonia Highlighted in Documentary Series Featuring former NFL Player Tim Shaw

“The Age of A.I.” Hosted by Robert Downey Jr. Premieres Today on YouTube

Tuesday, December 10, 2019

ALS Therapy Development Institute Reflects on the Impact of Pete Frates and the Ice Bucket Challenge

Pete was a leader in the ALS community and the inspiration for the Ice Bucket Challenge, which helped raise millions of dollars for ALS research and awareness.

Tuesday, November 19, 2019

AT-1501, A Drug Discovered at the ALS Therapy Development Institute, Completes Phase I Trial

Anelixis Therapeutics, a for-profit clinical-stage development company that brought the drug through trial, announced on Monday, November 18, that they completed a Phase 1 safety and pharmacokinetic study of AT-1501 in healthy subjects and people living with ALS.

A complete list of press releases from the ALS Therapy Development Institute.

More ALS TDI Press Releases

Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!

Media Contact

We'd love to share our story with you. Speak to our team about our unique approach to end ALS.

marketing@als.net | 617.441.7200

ALS News & Stories